USA flag logo/image

An Official Website of the United States Government

SBIR Phase II: An Innovative Photobioreactor for Commercial Production of…

Award Information

Agency:
National Science Foundation
Branch:
N/A
Award ID:
79436
Program Year/Program:
2007 / SBIR
Agency Tracking Number:
0610926
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ALGAEN CORPORATION
925 W NORTHWEST BLVD Winston Salem, NC 27101-1215
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: Yes
 
Phase 2
Fiscal Year: 2007
Title: SBIR Phase II: An Innovative Photobioreactor for Commercial Production of Astaxanthin from Genetically Improved Haematococcus Pluvialis Strains
Agency: NSF
Contract: 0724411
Award Amount: $499,866.00
 

Abstract:

This Small Business Innovative Research (SBIR) Phase II reserach develops an innovative biotechnology for commercial production of natural astaxanthin using genetically improved microalgal strain(s) grown in a proprietary large-scale photobioreactor, and to demonstrate the effectiveness of the new strains in improving bioavailability of astaxanthin. The proposed R&D efforts aim to overcome the major weakness inherent in the present production of astaxanthin-enriched Haematococcus: poor bioavailability of astaxanthin for humans and animals. The company will use several genetically modified Haematococcus strains with remarkably improved bioavailability of astaxanthin. The major objectives of the Phase II research are to design, construct, and evaluate an innovative large-scale photobioreactor system for sustainable mass culture of these new strains. The improved production system will increase astaxanthin productivity by 1.5- to 2-fold with at least 30% cost reduction. The broader impacts of this technology will be to overcome two major hurdles for the Haematococcus-based astaxanthin industry. The application of this biotechnology will lead to major increases in astaxanthin sales by 2015. It will also result in job expansion in the Haematococcus-astaxanthin production and related industries (e.g., cosmetic, pharmaceutical, and nutraceutical). Reduction in the production costs will lead to decreasing prices, making astaxanthin more affordable to allow more people to take advantage of astaxanthin as a strong antioxidant for improving health and well-being.

Principal Investigator:

Fan L. Lu
PhD
3365774354
LF1230NC@YAHOO.COM

Business Contact:

Fan L. Lu
PhD
3365774354
LF1230NC@YAHOO.COM
Small Business Information at Submission:

Algaen Corporation
3488 Bramlet Mailbox 201 Clemmons, NC 27012

EIN/Tax ID:
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No